Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine (NCT04611022)
Intervention to Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine Series
🩺 Plain-English Summary (8th-Grade Level)
The educational intervention to be delivered by the PN(Patient Navigator) consists of "toolkit education materials" developed by the National Cancer Institute (NCI) and a small media intervention (i.e., video) that our research team has developed. The NCI-produced toolkit education materials consist of Power Point presentations, flyers, and posters that contain information about HPV(Human Papilloma Virus), HPV-related cancers, and the importance of the HPV vaccine series for adolescents (9-17 years old) and young adults (18-26 year old) who are eligible for the vaccine.
Who can join: Review the eligibility criteria below.
Location: University of Colorado Hospital — Denver, Colorado
Age range: 18 Years
🧪 Interventions in This Study
- HPV Educational Intervention (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Colorado Hospital — Denver, Colorado
📞 Contact the Study Coordinator
Phone: (303) 724-5445
Email: Sindy.Gonzalez@CUAnschutz.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Human Papilloma Virus
- TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers — Chicago, Illinois
- Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study — Albany, Georgia
- Impact of Standing Orders Optimization — Chapel Hill, North Carolina
- Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old — Boston, Massachusetts
- Impact of Financial Incentives — Chapel Hill, North Carolina
- Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test — San Salvador,
Explore by condition: All Human Papilloma Virus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.